EMA Authorised: Sitagliptin / Metformin hydrochloride Mylan (sitagliptin hydrochloride monohydrate;metformin hydrochloride) — Mylan Pharmaceuticals Limited

View source ↗

Summary

Authorised combination tablet of sitagliptin and metformin hydrochloride by Mylan Pharmaceuticals Limited for Type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Sitagliptin/metformin hydrochloride Mylan (sitagliptin hydrochloride monohydrate; metformin hydrochloride)

Snippet

Status: Authorised. Therapeutic area: Diabetes Mellitus, Type 2. MAH: Mylan Pharmaceuticals Limited. Decision date: 08/06/2026